A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3
Recruiting · NCT05916313 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3 | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, epithelial neoplasm, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2026-10-05 | NCT05916313 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cantonal Hospital of Aarau | Aarau | Switzerland | 2 |
| Erasmus Medisch Centrum-ROTTERDAM-50697 | Rotterdam | Netherlands | 4 |
| Hospital Del Mar | Barcelona | Spain | 98 |
| Hospital Universitario 12 de Octubre | Madrid | Spain | 359 |
| Klinikum der Universität München AÖR | München | Germany | 6 |
| Salzburg Cancer Research Institute | Salzburg | Austria | 2 |
| Scri Oncology Partners | Nashville | United States | 156 |
| University Hosp. Zurich | Zurich | Switzerland | 1 |
| University Hospital of Lausanne | Lausanne | Switzerland | 1 |
| University of California Irvine | Orange | United States | 49 |
| Universitätsklinikum Frankfurt | Frankfurt | Germany | 2 |
| Universitätsklinikum Tübingen | Tübingen | Germany | 57 |